Product Information
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1561 per EA under NDC 68462068601. Its NADAC has been published 285 times since Jan 13, 2021.
Strength
1 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462068601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA206662On Market Since
11/10/2020
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has been published 285 times since Jan 13, 2021, and over the history we have for it it has declined 74.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1561 per EA |
|---|---|
| All-time high | $0.6148 (Jan 13, 2021) |
| All-time low | $0.1561 (Jun 17, 2026) |
| 52-week high | $0.1769 |
| 52-week low | $0.1561 |
| Median price | $0.2303 |
| Average price | $0.2708 |
| Largest weekly change | -19.7% (Dec 22, 2021) |
| Weeks tracked | 285 |
| Tracking since | Jan 13, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1561 per EA (NDC 68462068601), effective Jun 24, 2026.
How has the price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has declined 74.6%. It has been tracked across 285 weekly CMS publications since Jan 13, 2021.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
Since Jan 13, 2021, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1561 (Jun 17, 2026) to a high of $0.6148 (Jan 13, 2021), with a median of $0.2303 per EA.
Are there cheaper alternatives to TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), but none are currently priced below it.
Who manufactures TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) (NDC 68462068601) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification